Skip to main content
. 2024 Dec 27;5:73. doi: 10.1186/s43556-024-00240-9

Fig. 5.

Fig. 5

Role of EGCG in inhibition of cancer growth. EGCG acts as an anti-cancer agent either by responding through the RTK pathway or by binding to its 67 -ligand-receptor (67-LR). RTK method mediates via RAS pathway regulating nuclear and cytosolic genes. RTK also alter PI3K-AKT pathway thereby inhibiting angiogenesis. EGCG regulates the process of apoptosis via FLA and TNFα